Cours Ocera Therapeutics Inc

Actions

02/11/17	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders
20/10/17	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®
23/08/17	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017
01/08/17	Ocera Therapeutics Reports Second Quarter 2017 Financial Results
01/06/17	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2,29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+1,63%	-2,74%	+17,91%	-18,09%	62,21 Md
UCB	+2,50%	+4,43%	+64,44%	+216,37%	59,45 Md
SAMSUNG BIOLOGICS CO.,LTD.	-0,92%	+28,60%	+28,60%	+28,60%	38,9 Md
CSL LIMITED	+0,37%	+9,93%	-55,35%	-65,11%	36,4 Md
BIOGEN INC.	+2,94%	+1,79%	+50,28%	-35,26%	29,52 Md
INCYTE CORPORATION	+2,32%	+6,51%	+56,62%	+76,65%	21,54 Md
MODERNA, INC.	+7,94%	-3,78%	+78,88%	-59,73%	19,7 Md
INNOVENT BIOLOGICS, INC.	+4,39%	-0,59%	-5,70%	+112,12%	16,18 Md
SWEDISH ORPHAN BIOVITRUM AB	+0,78%	-1,57%	+44,59%	+98,01%	15,89 Md
Moyenne	+2,20%	+1,46%	+31,14%	+39,28%	33,31 Md
Moyenne pondérée par Capi.	+2,02%	+1,87%	+29,74%	+44,31%